Skip to main content
. 2023 Jan 24;2023:1011063. doi: 10.1155/2023/1011063

Figure 6.

Figure 6

MiR-126-3p silencing in A549 cell line. (a) Absolute copy number of miR-126-3p quantified by digital droplet PCR in A549 treated with AMSC-derived supernatants from patients with lung adenocarcinoma or control basal media. (b) miR-126-3p silencing-based experiments at 24 hours in A549 conditioned with AMSC-derived supernatants from patients with lung adenocarcinoma, showing the decrease of the copy number of the endogenous miR-126-3p. Samples were normalized to the control condition. (c) MTS assay of the A549 after silencing of the endogenous miR-126-3p and treated with AMSC-derived supernatants from patients with lung adenocarcinoma, showing the significant decrease of cell proliferation after 24 hours. The effect was not reproducible in the control (d). ∗p < 0.05.